Clinical Trials Sponsored by Guidant Corporation

Total 6548 results

Guidant Corporation

Withdrawn

OPTIMA Bi-ventricular Capture Verification Study

Heart Failure

Canada
Guidant Corporation

Suspended

SALT - Success of Active Versus Passive Lead Fixation of Atrial Pacing/Sensing Electrodes (SALT)

Bradycardia

Sweden
Guidant Corporation

Completed

Prospective Registry of Pacemaker Patients Concerning Percentage of Right Ventricular Pacing, LVEF and NYHA Class

Atrial Fibrillation | Heart Block | Bradycardia | Sick Sinus Syndrome

Germany
Guidant Corporation

Completed

Canadian Registry of ICD Implant Testing Procedures

Ventricular Fibrillation
Guidant Corporation

Completed

Monitoring of Arrhythmias and HRV in Patients With Heart Failure Treated With the CRT Pacemaker Renewal TR2

Congestive Heart Failure

France
Guidant Corporation

Terminated

REBEAT Resynchronisation and Beta-Blocker European Trial

Heart Failure

Switzerland, Italy
Guidant Corporation

Completed

The 4-SITE Field Following Study (4-SITE FF) (4-SITE FF)

ICD and CRT-D Indicated Patients

Germany
Guidant Corporation

Completed

SCANCAP Scandinavian Automatic Capture Study

Bradycardia

Denmark
Guidant Corporation

Completed

INSURE: INcidence Free SUrvival Before and After Implantable Cardioverter Defibrillator (ICD) Replacement

Ventricular Fibrillation

Germany
Guidant Corporation

Completed

ELECTION - The Electrode Configuration Cardiac Resynchronization Therapy (CRT) Study (ELECTION) (ELECTION)

Heart Failure
Guidant Corporation

Completed

Austria Study - Analysis of Difference Between Active and Passive Fixation Leads

Heart Block | Bradycardia | Sick Sinus Syndrome

Austria
Guidant Corporation

Completed

PROTECT : Pacing to Protect Heart for Damage From Blocked Heart Vessel and From Re-opening Blocked Vessel(s)

Acute Myocardial Infarction

Netherlands
Guidant Corporation

Completed

Long Term Integrity Follow-up Evaluation (LEAD LIFE)

Sudden Cardiac Death
Guidant Corporation

Completed

VERRARI - "Are Ventricular Arrhythmic Episodes Reduced by Rate Response in ICDs?"

Ventricular Fibrillation

Germany
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA Modul 7 VRR

Atrial Fibrillation

Germany
Boston Scientific Corporation
Guidant Corporation

Completed

MODULA Modul 5 BEAT-HF

Heart Failure

Germany
Boston Scientific Corporation
Guidant Corporation

Terminated

MODULA-Study: Modul 10: Benefit of CRT-Therapy in CRT-Patients With QRS-Complex of 120 - 150 Ms

Heart Failure

Germany
Guidant Corporation
Boston Scientific Corporation

Completed

Cognis and Teligen 100 HE and Reliance Quadripolar Defibrillation Lead (4-Site) Field Following (Cogent-4)

Heart Failure | Ventricular Tachycardia, Ventricular Fibrillation

Israel, Denmark
Guidant Corporation
Boston Scientific Corporation

Completed

Comparison of Right Ventricular Septal and Right Ventricular Apical Pacing in Patients Receiving a CRT-D Device (SEPTAL-CRT)

Ventricular Fibrillation | Ventricular Tachycardia | Systolic Heart Failure

France, Spain
Boston Scientific Corporation
Guidant Corporation

Completed

Septal - Success Rate and Clinical Outcome of Septal Implant of Ventricular Defibrillation Lead

Ventricular Fibrillation | Ventricular Tachycardia

France
Boston Scientific Corporation
Guidant Corporation

Completed

Shockless Implant Evaluation (SIMPLE)

Ventricular Fibrillation | Ventricular Tachycardia

Germany, Spain, Canada, Israel, Netherlands, France, Finland, United Kingdom, Austria, Malaysia, Thailand, Hong Kong, Sweden, Hungary, Australia, Czechia, Norway, Poland
Boston Scientific Corporation
Guidant Corporation

Completed

Feature Assessment Study for Indications Based Programming (FASt-IBP)

Heart Failure | Ventricular Fibrillation | Ventricular Tachycardia | Ventricular Flutter

Germany, Spain, Switzerland, China, Austria, Belgium, France, Greece, Latvia, Netherlands, Slovakia
Boston Scientific Corporation
Guidant Corporation

Completed

Japanese Assessment of Indication Based Programming (JASMINE)

Heart Failure | Arrhythmias, Cardiac

Japan
Boston Scientific Corporation
Guidant Corporation

Completed

Quick ICD Study: Is Extensive Electrophysiological Testing Before, During and After ICD-Implantation Still Necessary ? (Quick ICD)

Cardiac Arrest

Germany
Abbott Medical Devices
Guidant Corporation

Completed

Post-Approval Study of the Guidant Carotid Stent Systems and Embolic Protection Systems: CAPTURE

Atherosclerotic Disease, Carotid

United States
Guidant Corporation
University of Rochester

Completed

Next Generation INCEPTA Implantable Cardioverter Defibrillator (ICD) and Cardiac Resynchronization Therapy (CRT-D) Field Following Study (NOTICE-HF)

Heart Failure | Sudden Cardiac Death

Germany
University of California, Davis
Guidant Corporation

Withdrawn

Ventricular Rate Regularization for Improved Quality of Life in Patients With CHF and AF (VRR)

Atrial Fibrillation | Congestive Heart Failure
Hennepin Healthcare Research Institute
Guidant Corporation

Completed

Prospective Minnesota Study of ECHO Tissue Doppler Imaging in Cardiac Resynchronization Therapy

Heart Failure

United States
Gold, Herman K., MD
Guidant Corporation

Unknown

PROVIDENCE:Prevention of Restenosis With Oral Rosiglitazone and the Vision Stent in Diabetics With Coronary Lesions

Coronary Artery Disease | Diabetes Mellitus

United States
Charles Berul
Medtronic; Guidant Corporation

Terminated

Pediatric Lead Extractability and Survival Evaluation (PLEASE)

Ventricular Fibrillation | Ventricular Tachycardia | Congenital Heart Disease | Cardiomyopathy | Long QT Syndrome

United States
PAMI Coordinating Center
Eli Lilly and Company; Guidant Corporation

Unknown

Senior PAMI: Primary Angioplasty Versus Thrombolytic Therapy for Acute Myocardial Infarction in the Elderly

Myocardial Infarction
John T. Nosek

Completed

Expert Guiding Technology to Help Individuals With Developmental Challenges Build Life and Vocational Skills

Intellectual Disability | Autism Spectrum Disorder

United States
Spanish Society of Cardiology
Sanofi; Fondo de Investigacion Sanitaria; Boston Scientific Corporation; Medtronic and other collaborators

Terminated

Thrombolysis Versus Primary Angioplasty for AMI in Elderly Patients (TRIANA)

Acute Myocardial Infarction

Spain
Rigshospitalet, Denmark
Medtronic; Abbott Medical Devices; Biosense Webster, Inc.; Guidant Corporation

Completed

A Randomized Trial of the Ostial Versus the Extra-Ostial Ablation Strategy for Atrial Fibrillation

Atrial Fibrillation | Arrhythmia

Denmark
Royal Brompton & Harefield NHS Foundation Trust
Medtronic; British Heart Foundation; Guidant Corporation; Schneider

Completed

The Stent or Surgery (SoS) Trial

Coronary Artery Disease
Canadian Heart Research Centre
Canadian Institutes of Health Research (CIHR); Hoffmann-La Roche; Guidant Corporation

Completed

Routine Angioplasty and Stenting After Fibrinolysis for Acute Myocardial Infarction

Myocardial Infarction

Canada
Guardant Health, Inc.

Recruiting

Screening for High Frequency Malignant Disease (SHIELD)

Lung Cancer

United States, France, Spain
Guiyang Medical University

Recruiting

TPF Induction Chemotherapy vs PF Adjuvant Chemotherapy Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced NPC

Locally Advanced Nasopharyngeal Carcinoma

China
Guardant Health, Inc.

Terminated

Registry of Guardant360® Use and Outcomes In People With Advanced Cancer (GEODE)

Non-small Cell Lung Cancer Metastatic

United States
Guiyang Medical University

Unknown

Docetaxel and Loplatin Induction Chemotherapy Followed by Concurrent Chemoradiotherapy for Locally Advanced SCCHN

Locally Advanced Head and Neck Squamous Cell Carcinoma

China
Guiyang Medical University

Completed

Antidepressants and Bone Mineral Density

Bone Mineral Density Quantitative Trait Locus 7
Guardant Health, Inc.

Recruiting

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation (ORACLE)

Renal Cell Carcinoma | Pancreatic Adenocarcinoma | Gastric Adenocarcinoma | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung Cancer | Fallopian Tube Carcinoma | Endometrial Carcinoma | Bladder Carcinoma | Esophageal Carcinoma | Invasive Breast Carcinoma | Cutaneous Melanoma | Epithelial Ovarian... and other conditions

United States
Guiyang Medical University

Not yet recruiting

Clinical Study of Radiotherapy Combined With Nedaplatin Contrast and Cisplatin for the Treatment of Locally Advanced Head and Neck Squamous Carcinoma

Head and Neck Squamous Carcinoma

China
Guardant Health, Inc.

Completed

Noninvasive vs. Invasive Lung Evaluation (NILE)

Non-Small Cell Lung Cancer
Guardant Health, Inc.

Completed

Guardant360® Test-Related Clinical Outcomes in Patients Who Share Medical Records

Non-Hematologic Malignancy

United States
MedSIR
GUARDANT HEALTH

Completed

Spanish Lung Liquid vs. Invasive Biopsy Program (SLLIP) (SLLIP)

Lung Cancer

Spain
Guiyang Medical University

Unknown

GP-induced Chemotherapy Combined With IMRT and TPF-induced Chemotherapy Combined With IMRT in the Treatment of Distant Metastatic Nasopharyngeal Carcinoma

Advanced Nasopharyngeal Carcinoma

China
Guiyang Medical University

Unknown

the Study of Effect of Chronomodulated Chemotherapy on the Dendritic Cells Subsets in the Treatment of Advanced Nasopharyngeal Cancer

Locally Advanced Head and Neck Squamous Cell Carcinoma

China
Guardant Health, Inc.

Recruiting

SIBYL: obServation of Therapy Response With lIquid BiopsY evaLuation

Breast Cancer | Colorectal Cancer | Non-small Cell Lung Cancer

United States
Guardant Health, Inc.

Completed

Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer (GRECO-B)

Advanced Breast Cancer

United States

Clinical Trials Sponsored by Guidant Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations